
ALS patients receive a multidisciplinary evaluation every 3 months, including medical and psychosocial care. The centre works in partnership with the ALS-PACA home care network and provides training for medical and paramedical professionals. We also participate in national training programs. The centre is particularly involved in international therapeutic trials and European academic trials and has developed its own specific research area focused on the development of brain-computer interfaces as an alternative communication system.
Contact
LocationHôpital Pasteur 2 – CHU de Nice 30 Voie Romaine 06001 Nice France
Experts
Current trials
Active
Phase iii
PHOENIX trial
Industry trial
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035' for the treatment of ALS.
Active
Phase iii
ADORE trial
Industry trial
Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).